SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-10-170516
Filing Date
2010-07-29
Accepted
2010-07-29 15:12:59
Documents
11
Period of Report
2010-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 574706
2 CERTIFICATION OF PEO PURSUANT TO RULE 13A-14(A) OR RULE 15D-14(A) dex311.htm EX-31.1 6178
3 CERTIFICATION OF PFO PURSUANT TO RULE 13A-14(A) OR RULE 15D-14(A) dex312.htm EX-31.2 6191
4 CERTIFICATION BY THE PEO & PFO AS REQUIRED BY RULE 13A-14(B) OR RULE 15D-14(B) dex321.htm EX-32.1 3545
11 GRAPHIC g27551g16o35.jpg GRAPHIC 14609
  Complete submission text file 0001193125-10-170516.txt   2352952

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT pdli-20100630.xml EX-101.INS 250941
6 XBRL TAXONOMY EXTENSION SCHEMA pdli-20100630.xsd EX-101.SCH 14167
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pdli-20100630_cal.xml EX-101.CAL 37411
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pdli-20100630_def.xml EX-101.DEF 106116
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE pdli-20100630_lab.xml EX-101.LAB 127113
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pdli-20100630_pre.xml EX-101.PRE 121179
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19756 | Film No.: 10977610
SIC: 2836 Biological Products, (No Diagnostic Substances)